Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 1048 entries
View as:

Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06841159 Org: User:
Start: 03/01/24 End: 03/01/28 Due: 03/01/29

Acute and Chronic Pain After Video-assisted Thoracoscopic Surgery for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05478460 Org: User:
Start: 08/10/21 End: 07/21/22 Due: 07/21/23

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00921531 Org: User:
Start: 06/30/09 End: 04/30/13 Due: 04/30/14

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06957938 Org: User:
Start: 04/28/25 End: 05/01/31 Due: 05/01/32

Prepectoral and Subpectoral Implant-based Breast Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT04688697 Org: User:
Start: 05/12/21 End: 12/31/25 Due: 12/31/26

PD-1 Inhibitors With or Without Radiation in Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05498805 Org: User:
Start: 08/15/22 End: 08/15/25 Due: 08/15/26

Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03926091 Org: User:
Start: 04/01/19 End: 11/01/25 Due: 11/01/26

Intraoperative Infusion of Methylene Blue for Prevention of Postoperative Delirium and Cognitive Dysfunction in Elderly Patients Undergoing Major Elective Noncardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04341844 Org: User:
Start: 01/14/19 End: 07/30/20 Due: 07/30/21

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04997837 Org: User:
Start: 07/21/21 End: 10/21/27 Due: 10/21/28

Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04741633 Org: User:
Start: 04/01/20 End: 12/31/22 Due: 12/31/23

Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE)

Phase: N/A Priority: Normal
NCT ID: NCT06455124 Org: User:
Start: 05/08/24 End: 12/30/29 Due: 12/30/30

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)

Phase: N/A Priority: Normal
NCT ID: NCT00817583 Org: User:
Start: 01/31/09 End: 07/31/11 Due: 07/31/12

Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT04665648 Org: User:
Start: 06/01/21 End: 12/31/24 Due: 12/31/25

ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)

Phase: N/A Priority: Normal
NCT ID: NCT03786003 Org: User:
Start: 02/09/22 End: 02/09/28 Due: 02/09/29

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

Phase: N/A Priority: Normal
NCT ID: NCT02140437 Org: User:
Start: 03/31/14 End: 06/30/16 Due: 06/30/17

Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04996459 Org: User:
Start: 03/01/20 End: 06/30/22 Due: 06/30/23

The Effect of Information Support Program on Self-efficacy of Prostate Cancer Patients During Hormonal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04340713 Org: User:
Start: 11/22/18 End: 02/29/20 Due: 02/28/21

Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01310478 Org: User:
Start: 08/31/10 End: - Due: -

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Phase: N/A Priority: Normal
NCT ID: NCT02633553 Org: User:
Start: 01/10/18 End: 12/31/29 Due: 12/31/30

Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell

Phase: N/A Priority: Normal
NCT ID: NCT04520035 Org: User:
Start: 08/01/20 End: 12/31/21 Due: 12/31/22

SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)

Phase: N/A Priority: Normal
NCT ID: NCT04527419 Org: User:
Start: 02/09/22 End: 02/09/27 Due: 02/09/28

Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT04766515 Org: User:
Start: 09/01/20 End: 08/31/25 Due: 08/31/26

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

Phase: N/A Priority: Normal
NCT ID: NCT06699472 Org: User:
Start: 10/31/24 End: 09/30/27 Due: 09/30/28

TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

Phase: N/A Priority: Normal
NCT ID: NCT02641847 Org: User:
Start: 01/31/16 End: 12/31/27 Due: 12/31/28

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03089099 Org: User:
Start: 04/24/17 End: 04/30/19 Due: 04/30/20